Stock listing

BOATS:DWTX Dogwood Therapeutics, Inc. Stock

US listing (BOATS) of Dogwood Therapeutics, Inc. · home listing NASDAQ:DWTX

Follow Dogwood Therapeutics, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:DWTX

$1.28 USD +0.24 (+23.1%)

Close on Nov 6, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:DWTX

Past year -75.4% · daily closes, Nov 6, 2025 – Nov 6, 2026, adjusted for splits
Day range
$1.08 – $1.37 USDNov 6, 2026
Volume
167,102 sharesNov 6, 2026
Market cap
$43.51M USDAt the close on Nov 6, 2026 · price × 33.99M shares outstanding
52-week range
$0.901 – $7.04 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
Traded on an average day
$132,464 USDMedian day 64,400 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Dogwood Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:DWTX · Home$1.28 USD+0.24 (+23.1%)167,102$1.19$1.37$1.081$1.04Close on Nov 6, 2026

Daily closes

Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:DWTX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.28+0.24+23.1%$1.19$1.37$1.081167,102
$1.04+0.01+1.0%$1.05$1.06$0.91171,630
$1.03-0.01-1.0%$1.04$1.10$1.03123,124
$1.04-0.18-14.8%$1.17$1.19$0.901423,391
$1.22-0.06-4.7%$1.293$1.293$1.2038,847
$1.28+0.05+4.1%$1.30$1.355$1.2857,786
$1.23-0.01-0.8%$1.24$1.38$1.1995,647
$1.24+0.08+6.9%$1.17$1.30$1.1755,879
$1.16+0.05+4.5%$1.11$1.17$1.1026,635
$1.11-0.01-0.9%$1.122$1.16$1.0739,459
$1.120.000.0%$1.15$1.205$1.1224,570
$1.12-0.05-4.3%$1.15$1.17$1.1064,600
$1.17+0.02+1.7%$1.14$1.21$1.1339,700
$1.15-0.06-5.0%$1.22$1.262$1.1449,400
$1.21-0.01-0.8%$1.40$1.40$1.18226,200
$1.22-0.03-2.4%$1.26$1.30$1.2069,900
$1.25-0.02-1.6%$1.28$1.294$1.182100,400
$1.27-0.03-2.3%$1.31$1.34$1.2483,100
$1.30-0.07-5.1%$1.37$1.38$1.29109,200
$1.37-0.03-2.1%$1.42$1.46$1.3743,900
$1.40-0.01-0.7%$1.45$1.54$1.4066,300
$1.41-0.02-1.4%$1.48$1.48$1.4162,500
$1.43-0.09-5.9%$1.50$1.51$1.4350,300
$1.520.000.0%$1.57$1.64$1.46125,600
$1.52+0.06+4.1%$1.50$1.72$1.4599,800
$1.46+0.03+2.1%$1.45$1.56$1.4371,100
$1.43+0.08+5.9%$1.36$1.45$1.3526,500
$1.350.000.0%$1.35$1.39$1.3234,300
$1.35-0.01-0.7%$1.38$1.445$1.3079,600
$1.360.000.0%$1.40$1.46$1.3582,100
$1.36-0.07-4.9%$1.44$1.521$1.3446,400
$1.43-0.08-5.3%$1.51$1.555$1.4217,200
$1.510.000.0%$1.51$1.57$1.4523,600
$1.51-0.09-5.6%$1.63$1.76$1.48128,200
$1.60-0.09-5.3%$1.67$1.73$1.5861,700
$1.69-0.03-1.7%$1.74$1.83$1.60116,200
$1.72+0.02+1.2%$1.80$1.80$1.7048,000
$1.70-0.03-1.7%$1.80$1.84$1.6784,300
$1.73-0.115-6.2%$1.81$1.84$1.7231,900
$1.845-0.095-4.9%$1.94$2.015$1.77120,800
$1.94+0.06+3.2%$1.88$2.00$1.8353,100
$1.88-0.06-3.1%$1.94$1.95$1.8340,600
$1.94-0.10-4.9%$2.125$2.15$1.89539,200
$2.04-0.25-10.9%$2.29$2.344$2.0485,900
$2.29-0.07-3.0%$2.37$2.38$2.25170,200
$2.36-0.12-4.8%$2.46$2.59$2.3446,700
$2.48-0.15-5.7%$2.60$2.66$2.4550,400
$2.63+0.05+1.9%$2.70$2.725$2.55145,100
$2.58-0.07-2.6%$2.61$2.74$2.53564,200
$2.65+0.33+14.2%$2.36$2.70$2.35134,500
$2.32-0.34-12.8%$2.64$2.64$2.3267,300
$2.66-0.02-0.7%$2.70$2.80$2.60120,600
$2.68+0.12+4.7%$2.64$2.68$2.53123,000
$2.56+0.07+2.8%$2.51$2.77$2.5099,700
$2.49+0.16+6.9%$2.31$2.576$2.31123,400
$2.33+0.02+0.9%$2.27$2.39$2.1059,300
$2.31+0.17+7.9%$2.22$2.41$2.1199,100
$2.14+0.08+3.9%$2.09$2.18$2.0632,600
$2.06-0.09-4.2%$2.15$2.24$2.0045,500
$2.15+0.17+8.6%$1.95$2.15$1.831105,800
$1.98+0.055+2.9%$1.92$2.005$1.8922,300
$1.925+0.085+4.6%$1.85$2.075$1.84558,400
$1.84+0.01+0.5%$1.83$1.85$1.7552,500
$1.83+0.025+1.4%$1.81$1.85$1.7326,400
$1.805+0.055+3.1%$1.765$1.805$1.7656,700
$1.75-0.08-4.4%$1.80$1.835$1.6565,900

Splits

1 split · NASDAQ:DWTX · every price before a split is adjusted for it

DayRatioWhat
1-for-25Consolidation
Ticker
BOATS:DWTX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BOATS
Currency
USD

What changed lately

Calls

Replays

  • Virios Therapeutics, Inc. (VIRI) Q2 2024 Earnings Call

    Wed, Aug 07, 2024 · 2:00 PM ET

    Watch Transcript
  • Virios Therapeutics, Inc. (VIRI) Q1 2024 Earnings Call

    Thu, May 09, 2024 · 8:30 AM ET

    Watch Transcript
  • Virios Therapeutics, Inc. (VIRI) Q3 2023 Earnings Call

    Mon, Nov 13, 2023 · 8:30 AM ET

    Watch Transcript

Latest news

All Dogwood Therapeutics, Inc. news

Financings

  • Private placement of private placement

    Nov 5, 2026

    Closed: US$5M raised · US$1.22 a share

    Buyers: CK Life Sciences Int’l., (Holdings) Inc. ($5 million investment through a subsidiary; the Company's largest shareholder); Sealbond Limited ($5 million private placement; largest shareholder, subsidiary of CK Life Sciences Int’l., (Holdings) Inc.)

    Use of proceeds: Phase 3 preparatory activities for Halneuron, working capital and general corporate purposes

    Announced Oct 19, 2026 · Closed Nov 5, 2026

  • Registered direct offering of shares of common stock (or pre-funded warrants) with warrants, via registered direct offering and concurrent private pla

    Jan 12, 2026

    Announced: up to US$12.5M · US$2.85 a share · ½ warrant at US$3.28 for 66 months · Maxim Group LLC

    Dealers: Maxim Group LLC (lead)

    Use of proceeds: Advance clinical development of Halneuron, working capital and general corporate purposes

    Announced Jan 12, 2026

  • Registered direct offering of common stock

    Mar 13, 2025

    Announced: about US$4.8M · US$8.26 a share · Maxim Group LLC

    Dealers: Maxim Group LLC (lead)

    Use of proceeds: Advance clinical development of Halneuron, working capital and general corporate purposes

    Announced Mar 13, 2025

Read by 6ix AI from the company's releases

Decks

Dogwood Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
21 in the last 12 months · 110 in all · newest Nov 5, 2026 · oldest 2021
Calls
12 calls with a replay · 12 with a transcript · latest Aug 7, 2024
Decks
14 decks · latest September 2026

Where Dogwood Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:DWTX · Home listingNASDAQUnited StatesUSD
BOATS:DWTX · This pageBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Dogwood Therapeutics, Inc.